Bavarian Nordic (OTCMKTS:BVNRY) Shares Gap Up – Here’s What Happened

Bavarian Nordic (OTCMKTS:BVNRY) gapped up before the market opened on Friday . The stock had previously closed at $9.9550, but opened at $10.96. Bavarian Nordic shares last traded at $10.9720, with a volume of 23,599 shares trading hands.

Bavarian Nordic Price Performance

The firm has a market cap of $2.60 billion, a price-to-earnings ratio of 14.37 and a beta of 1.20. The firm’s fifty day moving average is $9.27 and its two-hundred day moving average is $9.68.

Bavarian Nordic (OTCMKTS:BVNRY) last announced its earnings results on Friday, August 21st. The company reported $0.46 earnings per share (EPS) for the quarter. Bavarian Nordic had a net margin of 19.74% and a return on equity of 9.32%.

Bavarian Nordic Company Profile

Bavarian Nordic is a fully integrated biotechnology company specializing in the development, manufacture and commercialization of vaccines and immunotherapies. Founded in 1994 and headquartered in Martinsried, Germany, the company combines internal research capabilities with in-house manufacturing to address serious infectious diseases and cancer indications. Bavarian Nordic’s operations encompass preclinical research, clinical development and commercial supply, with a strategic focus on leveraging its proprietary viral vector platforms.

The company’s commercial portfolio includes approved prophylactic vaccines such as Jynneos™ (marketed as Imvamune®/Imvanex®) for the prevention of smallpox and monkeypox in the United States, European Union and Canada; Rabipur® for rabies prevention; and Encepur® against tick-borne encephalitis.